Profile

Cover photo
Kyle Ramer
Lives in Los Angeles, CA
4 followers|4,945 views
AboutPostsPhotosVideos+1's

Stream

Kyle Ramer changed his profile photo.

Shared publicly  - 
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
Inovio (INO) new abstract tuesday march 25th
Click link here to INO abstract Co-administration of Molecular adjuvants
Click link here to INO abstract Co-administration of Molecular adjuvants
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
Inovio (INO) New Interview with Dr. Kim about Inovio's research and treatment for cancer.
Money Matters 14-11 Hosts :   David Ebner of Merrill Lynch & Charlie Shields of Wells Fargo Advisors, LLC Guests :   J. Joseph Kim, Ph. D., CEO, of Inovio Pharmaceuticals Description :   Dave & Charlie talk about investing and then interview Dr. Kim about I...
Money Matters 14-11 Hosts:   David Ebner of Merrill Lynch & Charlie Shields of Wells Fargo Advisors, LLC Guests:   J. Joseph Kim, Ph. D., CEO, of Inovio Pharmaceuticals Description:   Dave & Charlie talk about investing...
1
Add a comment...
 
OncoSec (ONCS)June 26-27th, 2014 4th European Post Chicago Melanoma/ Skin Cancer Meeting
Results and Interpretations of ASCO presentations 2014  (Global confernce on news in melanoma/skin cancer)  Friday, June 27th 2014 Session- New drugs and trials: An update on immunotherapy and chemotherapy  9:36- Electroporation (Adil I. Daud) In addition P...
Results and Interpretations of ASCO presentations 2014  (Global confernce on news in melanoma/skin cancer)  Friday, June 27th 2014 Session- New drugs and trials: An update on immunotherapy and chemotherapy  9:36- Elect...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
OncoSec Medical (ONCS) May 21-24, 2014 ASGCT 17th Annual Meeting
Scientific  Symposium 213 Thursday May 22, 2014 Richard Heller, PHD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase 1 and 2 Trials Electrotransfer of plasmids encoding cytokines directly to tumors has been shown to genera...
Scientific Symposium 213 Thursday May 22, 2014 Richard Heller, PHD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase 1 and 2 Trials Electrotransfer of plasmids encoding cytokines...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
(Inovio) DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques
Abstract 3/13/2014 We tested the concept of combining DNA with protein to improve anti-HIV Env systemic and mucosal humoral immune responses. Rhesus macaques were vaccinated with DNA, DNA&protein co-immunization or DNA prime followed by protein boost, and t...
Abstract 3/13/2014 We tested the concept of combining DNA with protein to improve anti-HIV Env systemic and mucosal humoral immune responses. Rhesus macaques were vaccinated with DNA, DNA&protein co-immunization or DNA prim...
1
Add a comment...
Have him in circles
4 people
Olivier Libouban's profile photo
Bernie Armstrong's profile photo
eiseyem's profile photo
Thomas Montgomery Jr's profile photo

Kyle Ramer

Shared publicly  - 
 
iCo Therapeutics Inc: Conference & Catalyst
Summary Phase 2 trial for the treatment of diabetic macular edema (DME). ICo-007 Potential advantages, insight from a M.D. PhD, Medicine, Immunology. Conference Preview ( OTCQX:ICOTF ). IDEAL Study: A Randomized, Multi-center, Phase II Study of the safety, ...
Summary Phase 2 trial for the treatment of diabetic macular edema (DME). ICo-007 Potential advantages, insight from a M.D. PhD, Medicine, Immunology. Conference Preview (OTCQX:ICOTF). IDEAL Study: A Randomized, Multi-center,...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
Inovio (INO) New Interview with Dr. Kim about Inovio's research and treatment for cancer.
Money Matters 14-11 Hosts :   David Ebner of Merrill Lynch & Charlie Shields of Wells Fargo Advisors, LLC Guests :   J. Joseph Kim, Ph. D., CEO, of Inovio Pharmaceuticals Description :   Dave & Charlie talk about investing and then interview Dr. Kim about I...
Money Matters 14-11 Hosts:   David Ebner of Merrill Lynch & Charlie Shields of Wells Fargo Advisors, LLC Guests:   J. Joseph Kim, Ph. D., CEO, of Inovio Pharmaceuticals Description:   Dave & Charlie talk about investing...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
INOVIO (INO) CANCER ANTIBODIES CONFERENCE
CANCER ANTIBODIES VACCINES/ADJUVANTS & DELIVERY 17-19 September 2014, Switzerland (INOVIO will co-sponsor this conference) "This CAVAD 2014 conference brings together  experts in both fields of mabs and vaccines to address these important issues. CAVAD 2014...
CANCER ANTIBODIES VACCINES/ADJUVANTS & DELIVERY 17-19 September 2014, Switzerland (INOVIO will co-sponsor this conference) "This CAVAD 2014 conference brings together  experts in both fields of mabs and vaccines to address th...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
Inovio (INO) March 2014 Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine
Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine  [Epub ahead of print] Jian Yan a ,  Daniel O. Villarreal b ,  Trina Racine c ,  Jaemi S. Chu b ,  Jewell N. Walters b ,  Matthew P. Morrow a , Amir S. Khan a ,  Niranjan Y. Sar...
Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine [Epub ahead of print] Jian Yana,  Daniel O. Villarrealb,  Trina Racinec,  Jaemi S. Chub,  Jewell N. Waltersb,  Matthew P. Morrowa, Amir S. Khana,...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
OncoSec Medical (ONCS) May 21-24, 2014 ASGCT 17th Annual Meeting
Thursday, May 22nd, 2014 Richard Heller, PhD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase I and II Clinical Trials Electrotransfer of plasmids encoding cytokines directly to tumors has been shown to generate a local an...
Thursday, May 22nd, 2014 Richard Heller, PhD Non-Viral Gene Transfer of pIL-12 for the Treatment of Melanoma: Results from Phase I and II Clinical Trials Electrotransfer of plasmids encoding cytokines directly to tumo...
1
Add a comment...

Kyle Ramer

Shared publicly  - 
 
Inovio VGX-1027
VGX™-1027
anti-inflammatory drug VGX™-1027 is an orally administered, small molecule drug for
inflammatory diseases. A novel inhibitor of pro-inflammatory responses
including TNF-alpha, this drug has demonstrated preclinical efficacy against
Crohn’s disease...
VGX™-1027 anti-inflammatory drug VGX™-1027 is an orally administered, small molecule drug for inflammatory diseases. A novel inhibitor of pro-inflammatory responses including TNF-alpha, this drug has demonstrated preclinical...
1
Add a comment...
People
Have him in circles
4 people
Olivier Libouban's profile photo
Bernie Armstrong's profile photo
eiseyem's profile photo
Thomas Montgomery Jr's profile photo
Places
Map of the places this user has livedMap of the places this user has livedMap of the places this user has lived
Currently
Los Angeles, CA
Links
YouTube
Work
Skills
Medical Coding, Medical terminology, Electronic Health Records
Employment
  • Investor, Market Researcher, present
  • N/a
    Medical Coder
Basic Information
Gender
Male
Kyle Ramer's +1's are the things they like, agree with, or want to recommend.
Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and ...
www.frontiersin.org

In recent years, DNA vaccines have undergone a number of technological advancements that have incited renewed interest and heightened promis

Google announces Calico, a new company focused on health and well-being ...
googlepress.blogspot.com

MOUNTAIN VIEW, CA – September 18, 2013 – Google today announced Calico, a new company that will focus on health and well-being, in particula

Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall ...
finance.yahoo.com

BLUE BELL, Pa., Sept. 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, Presiden